We recapitulated these functional interactions among p16INK4a/RB1, Pten, and Ras oncogenic pathways, resulting in a highly aggressive tumor phenotype in our model that will be useful for high-throughput screens, for example done in parallel with mouse studies. This evidence concerns the gene CDKN2A and neoplasm.